相关实验视频
Updated: Jun 1, 2025

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
基因组胺途径是治疗肝脏实验性人造蛋白质原体的目标
Ning Kuo1, Pei Li2, Juliana Bragazzi Cunha3
1Robert Wood Johnson Medical School, and Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey; Current affiliation: Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, California.
环素是一种抗胰岛素,可降低红色素原症 (EPP) 的实验模型中的protoporphyrin-IX (PP-IX) 积累. 这一发现表明抗组胺剂可以通过降低PP-IX水平来治疗与EPF相关的肝病.
科学领域:
- 生物化学 生物化学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 红色人体原性病 (EPP) 由铁甲酸酶突变引起,导致原素-IX (PP-IX) 积累和肝脏疾病.
- 目前对EPP的治疗主要针对光敏感性,留下了管理与EPP相关的肝脏并发症的重大未满足需求.
研究的目的:
- 为了确定EPP相关的肝病的新疗法策略.
- 调查组胺在PP-IX积累中的作用,并探索抗组胺剂作为潜在的治疗方法.
主要方法:
- 利用斑马鱼,小鼠初级肝细胞和两种EPP小鼠模型 (转基因和DDC诱导) 来研究PP-IX水平.
- 用德尔塔氨基氨酸 (ALA) 和德费洛克萨 (DFO) 诱导PP-IX的过度生产,然后进行高通量查.
- 通过光,肝脏组织学,免疫包裹和qPCR评估PP-IX水平;分析核受体激活和转运体表达.
主要成果:
- 环显著降低了斑马鱼,DDC养小鼠和EPF小鼠的肝脏PP-IX水平.
- 组胺加剧了PP-IX的积累,而H1/H2受体阻断则减少了它.
- 环改善了EPP小鼠的肝损伤,减少了氧化应激,增强了PP-IX清除,特别是在雌性小鼠中.
结论:
- 组胺在EPP模型中对PP-IX积累有显著的贡献.
- 环素和其他抗组胺药物通过减轻PP-IX的积累来治疗与EPF相关的肝病,这是一种有前途的治疗途径.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Erythropoiesis
Export of Misfolded Proteins out of the ER
Enzyme Inhibition

